Answers are grounded in this paper and cite their sources.
In the past two decades, microRNAs have emerged as crucial mediators of organ development and human disease. Here, we discuss their role as drivers or suppressors of the hallmarks of cancer during tumorigenesis and progression, in defining interpatient heterogeneity and the promise of therapeutic application.
No takes yet. Share an insight, caveat, or question.
Nana‐Sinkam et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: